CN Patent

CN1859908A — 作为s1p受体激动剂的3,5－芳基、杂芳基或环烷基取代的－1,2,4－噁二唑类化合物

Assigned to Merck and Co Inc · Expires 2006-11-08 · 20y expired

What this patent protects

本发明包括式I化合物：(I)以及其可药用的盐。该化合物可用于治疗免疫介导的疾病和病症，如骨髓、器官和组织移植排斥。还包括药物组合物以及其使用方法。

USPTO Abstract

本发明包括式I化合物：(I)以及其可药用的盐。该化合物可用于治疗免疫介导的疾病和病症，如骨髓、器官和组织移植排斥。还包括药物组合物以及其使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN1859908A
Jurisdiction
CN
Classification
—
Expires
2006-11-08
Drug substance claim
No
Drug product claim
No
Assignee
Merck and Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.